Tolerance and Digestibility of a New Formula in Healthy Infants
Phase 2
Completed
- Conditions
- SteatorrheaGrowth
- Interventions
- Dietary Supplement: dairy lipids and soluble milk proteins
- Registration Number
- NCT01184378
- Lead Sponsor
- Lactalis
- Brief Summary
The great majority of infants formula contain fats exclusively from vegetable oil. Nevertheless, the use of both vegetable and dairy lipids is on a real interest to obtain an infant formula closer to the nutritional composition of maternal milk.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- normal growth;
- considered as healthy by the investigator according to the medical interrogation and the clinical examination;
- receiving exclusively infant formula for at least 15 days.
- without any solid food during the month of the study
Exclusion Criteria
- Premature born children or small born weights;
- Children breast-fed or weaned for less than 15 days;
- Children with solid food
- Food allergy, particularly in milk proteins allergy , and lactose intolerance ;
- Tumoral, inflammatory, cardiac, lung, renal, digestive diseases(syndrome of malabsorption);
- Digestive pathology previous to the inclusion, in particular infectious (rotavirus, gastroenteritis) or functional symptoms (important stomach pains, colicky) having required a lot of change in formula quality;
- Children under medical treatment (ex: paracetamol).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control formula dairy lipids and soluble milk proteins formula containing only vegetable fats new formula dairy lipids and soluble milk proteins new formula with dairy lipids and soluble milk proteins
- Primary Outcome Measures
Name Time Method digestibility of lipids in formula during the 30d consumption period lipid content determination in feces during a 3 days period of collection after 15d and 30d of formula intake
- Secondary Outcome Measures
Name Time Method tolerance and growth during the 30d of formula intake
Trial Locations
- Locations (2)
Hopital Mère-Enfants
🇫🇷Rennes, France
Faculté de Médecine
🇫🇷Dijon, France